UNSPSC 51203103: Thymocartin

This classification denotes a therapeutic hormone with the molecular formula C21H40N8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) M0H0SK3AD5, chemically known as l-valine, n-(n-(n(sup 2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)- but more generally known as thymocartin, which bears US NIH Compound Identifier 3033954. European Medicines Agency schedules Thymocartin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10991MIG.

UNSPSC 51203103 Thymocartin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities present in the recent record involve pharmaceutical procurement but do not reflect thymocartin itself — one centers on antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin) and the other on naloxone and drug deactivation systems. The mismatch between the code name and the products actually solicited under the tag suggests either miscoding at source or a broad institutional use of this commodity code for general pharmaceutical warehouse and supply-chain contracting within state and local health agencies.

Illinois Department of Public Health and Seminole County, Florida are the two issuing bodies represented in the recent record. The Illinois procurement was a completed award through the MMCAP Infuse consortium piggyback vehicle to Chartwell Rx LLC for $2,999,999.11 over three contract years, while the Seminole County IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the county community health building. The source shows activity in Illinois and Florida; neither thymocartin nor products closely related to it appear in either opportunity. If thymocartin procurement does occur under this code at the state or local level, it is not reflected in current public solicitations.